IL142292A0 - Ion exchange tumor targeting - Google Patents
Ion exchange tumor targetingInfo
- Publication number
- IL142292A0 IL142292A0 IL14229299A IL14229299A IL142292A0 IL 142292 A0 IL142292 A0 IL 142292A0 IL 14229299 A IL14229299 A IL 14229299A IL 14229299 A IL14229299 A IL 14229299A IL 142292 A0 IL142292 A0 IL 142292A0
- Authority
- IL
- Israel
- Prior art keywords
- ion exchange
- tumor targeting
- tumor
- compound
- intratumoral
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 230000008685 targeting Effects 0.000 title abstract 2
- 238000005342 ion exchange Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229920002307 Dextran Polymers 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 abstract 1
- 230000002601 intratumoral effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
- A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803482A SE9803482D0 (sv) | 1998-10-13 | 1998-10-13 | Ion exchange tumor targeting (IETT) |
| PCT/SE1999/001837 WO2000021571A1 (en) | 1998-10-13 | 1999-10-12 | Ion exchange tumor targeting (iett) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL142292A0 true IL142292A0 (en) | 2002-03-10 |
Family
ID=20412924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14229299A IL142292A0 (en) | 1998-10-13 | 1999-10-12 | Ion exchange tumor targeting |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6569841B1 (de) |
| EP (1) | EP1137441B1 (de) |
| JP (1) | JP2002527407A (de) |
| AT (1) | ATE489971T1 (de) |
| AU (1) | AU759251B2 (de) |
| CA (1) | CA2347424C (de) |
| DE (1) | DE69943003D1 (de) |
| IL (1) | IL142292A0 (de) |
| NO (1) | NO20011817L (de) |
| SE (1) | SE9803482D0 (de) |
| WO (1) | WO2000021571A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20010764A0 (fi) * | 2001-04-11 | 2001-04-11 | Map Medical Technologies Oy | Kationiset dekstraanijohdannaiset käytettäväksi munuaisten suojaamiseen |
| US8377484B1 (en) | 2004-05-06 | 2013-02-19 | Maria V. Tsiper | Tumor encapsulation for prevention and treatment of metastatic cancer disease |
| CN101460523A (zh) * | 2006-04-07 | 2009-06-17 | 阿道恰公司 | 双官能化多糖 |
| FI119513B (fi) * | 2007-03-07 | 2008-12-15 | Dextech Medical Ab | Muokatut hydroksipolymeerikonjugaatit, joilla on tappava vaikutus tuumorisoluihin |
| FR2919189A1 (fr) * | 2007-07-26 | 2009-01-30 | Cyclopharma Sa Lab | Nouvelles compositions a base de polyosides greffes par des composes polyamines ou polysoufres. |
| US7998368B2 (en) * | 2007-11-26 | 2011-08-16 | United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Aqueous solution dispersement of carbon nanotubes |
| EP2274018B1 (de) * | 2008-04-07 | 2013-12-18 | Dextech Medical AB | Modifizierte Hydroxylpolymer-Konjugate mit Knochengewebe-gerichteten und Tumor-vernichtenden Gruppen |
| KR101450838B1 (ko) | 2012-02-08 | 2014-10-15 | 가톨릭대학교 산학협력단 | 표적화 화학요법을 위한 암 인식 지능형 폴리펩티드 및 이의 제조방법 |
| DE102014016901B4 (de) * | 2014-09-17 | 2021-08-12 | Friedrich-Schiller-Universität Jena | Verfahren zur Herstellung für neue Dextranderivate als Wirkstoffträgersystem und deren Verwendung |
| FI127538B (en) | 2016-06-22 | 2018-08-31 | Dextech Medical Ab | MODIFIED Dextran Conjugates |
| PL240772B1 (pl) * | 2018-06-11 | 2022-06-06 | Nanothea Spolka Akcyjna | Sposób wytwarzania nanocząstek polimerowych chelatujących izotopy promieniotwórcze do zastosowania w diagnostyce i terapii |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5051257A (en) | 1989-05-09 | 1991-09-24 | Pietronigro Dennis D | Antineoplastic solution and method for treating neoplasms |
-
1998
- 1998-10-13 SE SE9803482A patent/SE9803482D0/xx unknown
-
1999
- 1999-10-12 CA CA002347424A patent/CA2347424C/en not_active Expired - Lifetime
- 1999-10-12 AT AT99970330T patent/ATE489971T1/de not_active IP Right Cessation
- 1999-10-12 WO PCT/SE1999/001837 patent/WO2000021571A1/en not_active Ceased
- 1999-10-12 EP EP99970330A patent/EP1137441B1/de not_active Expired - Lifetime
- 1999-10-12 AU AU14247/00A patent/AU759251B2/en not_active Expired
- 1999-10-12 JP JP2000575543A patent/JP2002527407A/ja active Pending
- 1999-10-12 DE DE69943003T patent/DE69943003D1/de not_active Expired - Lifetime
- 1999-10-12 US US09/807,542 patent/US6569841B1/en not_active Expired - Lifetime
- 1999-10-12 IL IL14229299A patent/IL142292A0/xx unknown
-
2001
- 2001-04-10 NO NO20011817A patent/NO20011817L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US6569841B1 (en) | 2003-05-27 |
| EP1137441A1 (de) | 2001-10-04 |
| NO20011817D0 (no) | 2001-04-10 |
| JP2002527407A (ja) | 2002-08-27 |
| CA2347424C (en) | 2009-12-08 |
| WO2000021571A1 (en) | 2000-04-20 |
| CA2347424A1 (en) | 2000-04-20 |
| DE69943003D1 (de) | 2011-01-13 |
| EP1137441B1 (de) | 2010-12-01 |
| NO20011817L (no) | 2001-04-10 |
| AU1424700A (en) | 2000-05-01 |
| SE9803482D0 (sv) | 1998-10-13 |
| ATE489971T1 (de) | 2010-12-15 |
| AU759251B2 (en) | 2003-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1378499A (en) | Methods for treating prostate tumors using radioactive compositions | |
| IL142292A0 (en) | Ion exchange tumor targeting | |
| CY1109881T1 (el) | Νεοαγγειακα-συγκεκριμενα πεπτιδια | |
| TW581808B (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
| AU4932199A (en) | Cancer antigens based on tumor suppressor gene wt1 product | |
| GB9814527D0 (en) | Delivery system | |
| PL335140A1 (en) | Therapeutic agent for treating lymphatic system carcinomas | |
| BR0306715A (pt) | Métodos para diagnóstico e tratamento de tumores | |
| WO2000045853A3 (en) | Treatment of tumors with genetically engineered herpes virus | |
| BR0010590A (pt) | Emprego de filanto para estimulação objetivada do sistema imunológico | |
| AU4770297A (en) | Receptor-mediated gene transfer system for targeting tumor gene therapy | |
| EP1018548A4 (de) | Zusammensetzung mit alpha-glycosylceramid zur stärkung zellulärer immunogenität | |
| NZ504938A (en) | Tumor antigen peptide derivatives capable of binding to HLA-A24 antigen | |
| WO2004110255A3 (en) | Antineoplastic agents targeted via glut transporters | |
| CA2234263A1 (fr) | Composition pharmaceutique contre les tumeurs et infections a papillomavirus | |
| PL342614A1 (en) | Anticarcinogenic drugs | |
| BG106008A (en) | Novel lhrh antagonists with improved solubility characteristics | |
| AU3260093A (en) | Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours | |
| WO1999002704A3 (en) | Dual specifically phosphatase and methods of use | |
| WO2005007079A3 (en) | Inactivators and bivalent inhibitors of glyoxalase i and methods of inhibiting tumor growth | |
| AU5302599A (en) | Method for diagnosing bone metastasis of malignant tumor | |
| WO2000040752A3 (en) | Cancer associated genes and their products | |
| AU5992500A (en) | Compound derived from an offset orf of the ice gene | |
| AU6617498A (en) | Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemo- and radiotherapy | |
| TW200517125A (en) | Pharmaceutical composition for treatment of solid cancers |